Chris Young expected to return to Mets

2 Comments

We heard way back in December that the Mets were open to bringing back right-hander Chris Young on a minor league deal and now it appears as though a reunion could be right around the corner.

Andy Martino of the New York Daily News was told by a source that Young has narrowed his choices to the Mets or Padres and is “more inclined” to return to New York.

“It will happen,” the person said, predicting that Young will return to the New York.

The Mets need starting pitching depth in the worst way right now, but Young is no sure thing to contribute anytime soon. He is currently working his way back from May 2010 surgery to repair the anterior capsule muscle in his right shoulder. Current Mets’ starter Johan Santana underwent the same procedure in September of 2010 and missed the entire 2011 season. Young told ESPN’s Jerry Crasnick in January that he hopes to be pitching again by April.

Young, who turns 34 in May, posted a 1.88 ERA and 21/11 K/BB ratio over four starts with New York last season prior to the surgery. He has been limited to just 22 starts over the past three seasons due to shoulder woes.

UPDATE: Andy Martino notes on Twitter that a deal is “not imminent.”

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.